1. Search Result
Search Result
Results for "

Radiopharmaceutical

" in MedChemExpress (MCE) Product Catalog:

28

Inhibitors & Agonists

6

Biochemical Assay Reagents

3

Peptides

1

Natural
Products

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-129040A
    m-Iodobenzylguanidine sulfate
    1 Publications Verification

    MIBG sulfate; Iobenguane sulfate

    Adrenergic Receptor Cancer
    m-Iodobenzylguanidine sulfate (MIBG sulfate) is an analogue of the neurotransmitter norepinephrine with antitumor activity. Radioiodinated m-Iodobenzylguanidine sulfate is clinically used as a tumor-targeted radiopharmaceutical in the diagnosis and treatment of adrenergic tumors. m-Iodobenzylguanidine sulfate is a high-affinity substrate for cholera toxin that interferes with cellular mono(ADP-ribosylation) .
    m-Iodobenzylguanidine sulfate
  • HY-129650
    Florbetapir
    1 Publications Verification

    AV-45; Flobetapir

    Biochemical Assay Reagents Others
    Flobetapir (AV-45) may be a well-tolerated imaging agent. Flobetapir synthesizes Florbetapir (18F) that is a PET scanning radiopharmaceutical compound containing the radionuclide fluorine-18 .
    Florbetapir
  • HY-W102590

    Biochemical Assay Reagents Others
    DOTMP is a bifunctional chelator. Bifunctional chelating agents are used to stably link the radiometal to the carrier moiety of the radiopharmaceutical .
    DOTMP
  • HY-B1684

    SQ 26962

    Biochemical Assay Reagents Others
    Mebrofenin (SQ 26962) is a type of iminodiacetic acid (IDA). Mebrofenin is available as a ready to use the kit for radio-labeling with Tc-99m. Tc-99m Mebrofenin, a diagnostic agent, is used for hepatobiliary imaging. Tc-99m Mebrofenin is the radiopharmaceutical of choice for the evaluation of hepatic function .
    Mebrofenin
  • HY-159770A

    Radionuclide-Drug Conjugates (RDCs) Cancer
    (S)-EB-FAPI-B2 (Compound II-11) is a precursor for radiopharmaceutical labeling, which can be combined with radionuclides to create radionuclide drug conjugates (RDCs). RDCs have the capability to specifically target biomolecules and can be used in medical imaging .
    (S)-EB-FAPI-B2
  • HY-126369

    HM-PAO

    Biochemical Assay Reagents Others
    Exametazime (HM-PAO) is a lipophilic agent used for the preparation of brain imaging radiopharmaceuticals. 99Tcm-Exametazime is an effective in vitro leukocyte labeling agent .
    Exametazime
  • HY-P10369

    Biochemical Assay Reagents Radionuclide-Drug Conjugates (RDCs) Cardiovascular Disease Inflammation/Immunology
    Betiatide, as a chelating agent for Technetium-99m ( 99mTc), is used to prepare 99mTc-MAG3 (mercaptoacetyltriglycine), a radiopharmaceutical for renal function imaging. Betiatide is used for the diagnosis of congenital and acquired abnormalities, renal failure, urinary tract obstructions, and calculi . Betiatide can be used for the synthesis/research of Radionuclide-Drug Conjugates (RDCs).
    Betiatide
  • HY-W004649

    Biochemical Assay Reagents Others
    Tris-BOC-cyclen is a bifunctional chelator. Bifunctional chelating agentscan be used to stably link the radiometal to the carrier moiety of the radiopharmaceutical .
    Tris-BOC-cyclen
  • HY-W109978

    Biochemical Assay Reagents Others
    Tetrabutylammonium perrhenate is a quaternary ammonium salt belonging to the class of alkylammonium salts. This compound is used as a catalyst in organic synthesis, especially in the production of alkenes and alcohols. Furthermore, due to its ability to bind radioisotopes, it is useful as a radiopharmaceutical in nuclear medicine. Its unique chemical properties make it an essential ingredient in a variety of industrial processes, including petrochemical refining and pharmaceuticals.
    Tetrabutylammonium perrhenate
  • HY-P11088

    Transmembrane Glycoprotein Radionuclide-Drug Conjugates (RDCs) Inflammation/Immunology
    VCAM1 binding peptide is a VCAM1 binder with internalization activity. VCAM1 binding peptide can be labeled with 5-FAM. VCAM1 binding peptide serves as a component of biosensing systems for visualizing in vitro VCAM1 endocytic pathways. VCAM1 binding peptide forms the research and development basis for MacroP and NAMP, PET radiotracers targeting VCAM1. VCAM1 binding peptide is applicable to studies related to atherosclerosis .
    VCAM1 binding peptide
  • HY-159771

    FAP Cancer
    FAP6-19 is a fibroblast activation protein (FAP) targeting radioligand with a Kd of 18.2 nM. FAP6-19 selectively delivers therapeutic radioactive nuclides (such as 177Lu) to the tumor site by targeting the overexpressed FAP protein in the tumor microenvironment, achieving precise killing of cancer cells while minimizing radiation damage to healthy tissues. FAP6-19 exhibits extremely high total cellular uptake and good intracellular retention ability in HT1080 cells. After being labeled with 111In, FAP6-19 produced extremely high tumor/kidney and tumor/liver dose ratios in the mouse model with 4T1 tumors. FAP6-19 can be used in the research of solid tumors expressing FAP.
    FAP6-19
  • HY-W143890

    EHIDA

    Biochemical Assay Reagents Neurological Disease Metabolic Disease
    Etifenin can be used for production of non-toxic radiopharmaceuticals which are in regular radiodiagnostic use .
    Etifenin
  • HY-159767A

    Radionuclide-Drug Conjugates (RDCs) Cancer
    (S)-DOTAGA.(SA.FAPi)2 is a precursor for radiopharmaceutical labeling, which can be combined with radionuclides to create radionuclide drug conjugates (RDCs). RDCs have the capability to specifically target biomolecules and can be used in medical imaging .
    (S)-DOTAGA.(SA.FAPi)2
  • HY-W402032

    Biochemical Assay Reagents Others
    Bis-Cbz-cyclen is a bifunctional chelator. Bifunctional chelating agents are used to stably link the radiometal to the carrier moiety of the radiopharmaceutical .
    Bis-Cbz-cyclen
  • HY-129650R

    AV-45 (Standard); Flobetapir (Standard)

    Biochemical Assay Reagents Reference Standards Others
    Flobetapir (Standard) (AV-45 (Standard)) is the analytical standard of Flobetapir (HY-129650). This product is intended for research and analytical applications. Flobetapirmay is a well-tolerated imaging agent. Flobetapir synthesizes Florbetapir (18F) that is a PET scanning radiopharmaceutical compound.
    Florbetapir (Standard)
  • HY-W009310R

    Reference Standards Endogenous Metabolite Organoid Others
    Mebrofenin (Standard) is the analytical standard of Mebrofenin. This product is intended for research and analytical applications. Mebrofenin (SQ 26962) is a type of iminodiacetic acid (IDA). Mebrofenin is available as a ready to use the kit for radio-labeling with Tc-99m. Tc-99m Mebrofenin, a diagnostic agent, is used for hepatobiliary imaging. Tc-99m Mebrofenin is the radiopharmaceutical of choice for the evaluation of hepatic function .
    9-cis-Retinal (Standard)
  • HY-129040AR

    MIBG sulfate (Standard); Iobenguane sulfate (Standard)

    Adrenergic Receptor Reference Standards Cancer
    m-Iodobenzylguanidine (sulfate) (Standard) is the analytical standard of m-Iodobenzylguanidine (sulfate). This product is intended for research and analytical applications. m-Iodobenzylguanidine sulfate (MIBG sulfate) is an analogue of the neurotransmitter norepinephrine with antitumor activity. Radioiodinated m-Iodobenzylguanidine sulfate is clinically used as a tumor-targeted radiopharmaceutical in the diagnosis and treatment of adrenergic tumors. m-Iodobenzylguanidine sulfate is a high-affinity substrate for cholera toxin that interferes with cellular mono(ADP-ribosylation) .
    m-Iodobenzylguanidine sulfate (Standard)
  • HY-B1684R

    SQ 26962 (Standard)

    Biochemical Assay Reagents Reference Standards Others
    Mebrofenin (Standard) is the analytical standard of Mebrofenin. This product is intended for research and analytical applications. Mebrofenin (SQ 26962) is a type of iminodiacetic acid (IDA). Mebrofenin is available as a ready to use the kit for radio-labeling with Tc-99m. Tc-99m Mebrofenin, a diagnostic agent, is used for hepatobiliary imaging. Tc-99m Mebrofenin is the radiopharmaceutical of choice for the evaluation of hepatic function .
    Mebrofenin (Standard)
  • HY-167987

    Radionuclide-Drug Conjugates (RDCs) Cancer
    Guraxetan-NH-PEG3-TFP ester (Fig.3) is a chelating agent and linker conjugate that can be used in the synthesis of radiopharmaceuticals .
    Guraxetan-NH-PEG3-TFP ester
  • HY-167789

    Radionuclide-Drug Conjugates (RDCs) Cancer
    DOTA(tBu3)-PEG4-TFP is a chelating agent and linker conjugate that can be used in the synthesis of radiopharmaceuticals .
    DOTA(tBu3)-PEG4-TFP
  • HY-167790

    Radionuclide-Drug Conjugates (RDCs) Cancer
    2,3,5,6-Tetrafluorophenyl propionate-PEG3-amino-tetraxetan is a chelating agent and linker conjugate that can be used in the synthesis of radiopharmaceuticals .
    2,3,5,6-Tetrafluorophenyl propionate-PEG3-amino-tetraxetan
  • HY-185120

    Radionuclide-Drug Conjugates (RDCs) Drug Intermediate Cancer
    ProX1-(SS)-DOTAGA_R (Compound 25a) is the unbound radionuclide portion of the radiopharmaceutical and can be used for targeted delivery to diseases characterized by ACP3 expression .
    ProX1-(SS)-DOTAGA_R
  • HY-153130

    (S)-PSMA I&T; (S)-PNT-2002

    Drug Isomer PSMA Cancer
    (S)-Zadavotide guraxetan ((S)-PSMA I&T) is the S-isomer of EuK-Sub-kf-iodo-y-DOTAGA. (S)-Zadavotide guraxetan is a PSMA targeting compound .
    (S)-Zadavotide guraxetan
  • HY-185401

    MOFs Cancer
    ATSM is a ligand that forms complexes with Cu 2+, Ni 2+, Zn 2+, and Fe 2+, with the highest affinity for Cu 2+. ATSM forms Cu-ATSM with copper, which is used for PET imaging to detect tumor hypoxia. ATSM is commonly used in coordination chemistry and radiopharmaceutical research .
    ATSM
  • HY-186094

    Drug Derivative Drug Intermediate Neurological Disease
    (S,S)-Demethyl-reboxetine is a key phenolic precursor for the preparation of the PET tracer (S,S)-[ 11C]-MeNER. (S,S)-Demethyl-reboxetine is also the demethylated derivative of Reboxetine (HY-14560). Efficient synthesis of the norepinephrine transporter (NET)-targeted tracer is achieved through 11C methylation of (S,S)-Demethyl-reboxetine. (S,S)-Demethyl-reboxetine serves as a core raw material for the synthesis of radiopharmaceuticals related to NET imaging .
    (S,S)-Demethyl-reboxetine
  • HY-402737

    Drug Intermediate Others
    FTC-146 precursor (Compound s6) is a drug intermediate that can be used to prepare σ-1 receptor positron emission tomography tracers ([¹⁸F]FTC-146) .
    FTC-146 precursor
  • HY-178221

    Drug Intermediate Cancer
    (S)-P-SCN-BN-NOTA is a bifunctional chelating agent that can covalently link the radioactive nuclide ⁶⁴Cu with the ZPDGFRβ affibody, thereby constructing a molecular probe [⁶⁴Cu]Cu-NOTA-ZPDGFRβ for positron emission tomography .
    (S)-P-SCN-BN-NOTA
  • HY-153709

    IPN-01087

    Neurokinin Receptor Cancer
    Zalsenertant tetraxetan (IPN-01087) is a DOTA-conjugated antagonist of the neurohypophyseal hormone receptor subtype 1 (NTSR1). Zalsenertant tetraxetan is labeled with the radioactive isotope Lu-177 (177Lu), which can be used for molecular imaging to identify potential responders. Zalsenertant tetraxetan can be used in the radiotherapy research of solid tumors .
    Zalsenertant tetraxetan

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: